13FPulse
TR

TRVI TREVI THERAPEUTICS INC

2026Q2 · CUSIP 89532M101 · Sector: Healthcare & Biotech

Piling in

Net holder growth ranks near the top of the market

Funds that own it
215
Institutions that reported holding it to the SEC
Net increase in holders
+18
Last quarter 197 → now 215
How unusual is that
Top 20%
Stronger buying than 81% of US stocks
What the filings say, in one paragraph

215 funds held TRVI at the end of 2026Q2, up 18 from the quarter before. That is stronger buying than 81.4% of US stocks — among the most piled-into names this quarter. On the business itself, return on equity is -15.9%. TRVI has had 7 buying rushes in its history, and the price moved +8.3% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2019Q3: holders=20 2019Q4: holders=17 2020Q1: holders=20 2020Q2: holders=16 2020Q3: holders=16 2020Q4: holders=18 2021Q1: holders=19 2021Q2: holders=17 2021Q3: holders=18 2021Q4: holders=17 2022Q1: holders=22 2022Q2: holders=30 2022Q3: holders=39 2022Q4: holders=36 2023Q1: holders=35 2023Q2: holders=52 2023Q3: holders=54 2023Q4: holders=62 2024Q1: holders=79 2024Q2: holders=76 2024Q3: holders=92 2024Q4: holders=110 2025Q1: holders=137 2025Q2: holders=153 2025Q3: holders=164 2025Q4: holders=184 2026Q1: holders=197 2026Q2: holders=215 -27 -13.5 +0 +13.5 +27 14120226 19Q320Q221Q121Q422Q323Q224Q124Q425Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 7 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q2 Top 20%
2025Q2 Top 20% +26.2% +52.6%
2025Q1 Top 10% -8.3% +12.8%
2024Q1 Top 20% -3.6% +7.2%
2023Q2 Top 20% -7.6% -39.4%
2022Q3 Top 20%
2022Q2 Top 20%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
106
Change in large funds
+11
Total value they hold
$2.8B
Funds buying for the first time
45
Funds that sold out entirely
27
Price change that quarter
+27.0%
Funds holding puts (bearish)
1
Funds holding calls (bullish)
4

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
EPS (TTM)
$-0.34
EPS YoY
Revenue (TTM)
Revenue YoY
Net margin
ROE
-15.9%
Debt ratio
2.7%
FCF (TTM)
-$53M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2022-06-30: EPS -0.14 2022-09-30: EPS -0.12 2022-12-31: EPS 0.05 2023-03-31: EPS -0.06 2023-06-30: EPS -0.07 2023-09-30: EPS -0.08 2023-12-31: EPS -0.08 2024-03-31: EPS -0.11 2024-06-30: EPS -0.12 2024-09-30: EPS -0.13 2024-12-31: EPS -0.11 2025-03-31: EPS -0.09 2025-06-30: EPS -0.09 2025-09-30: EPS -0.08 2025-12-31: EPS -0.06 2026-03-31: EPS -0.09 2026-06-30: EPS -0.11 -0.15 -0.05 0.06 2022202320242025202606/26 EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

Quarterly free cash flow
-17M-8M0K 201820192020202120222023202420252026
Latest quarter $-17M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.